# Compass Therapeutics, Inc.: Form 8-K, filed Nov 3, 2021

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2021-11-03
- Accepted by EDGAR: Nov 3, 2021, 21:29 ET
- Period: 2021-11-01
- Accession: 0000950170-21-002863
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000095017021002863/cmpx-20211101.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000095017021002863/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000095017021002863/cmpx-20211101.htm

Filed Nov 3, 2021.
Source: SEC EDGAR, the filing index for accession 0000950170-21-002863. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.